https://www.thepeptidenewsroom.com/peptide-sciences-closure-draws-a-clinic-press-release-and-a-useful-regulatory-re/ The Peptide Newsroom en 2026-10-24 Peptide Sciences Closure Draws a Clinic Press Release, and a Useful Regulatory Reminder https://www.thepeptidenewsroom.com/healthline-editor-says-a-bialik-quote-on-glp-1-side-effects-drew-3-500-comments/ The Peptide Newsroom en 2026-10-24 Healthline Editor Says a Bialik Quote on GLP-1 Side Effects Drew 3,500 Comments https://www.thepeptidenewsroom.com/drug-safety-group-petitions-fda-to-halt-peptide-compounding-as-kennedy-pushes-st/ The Peptide Newsroom en 2026-10-24 Drug Safety Group Petitions FDA to Halt Peptide Compounding as Kennedy Pushes State Marketplace https://www.thepeptidenewsroom.com/ai-scan-of-150-000-reddit-posts-finds-gray-market-retatrutide-users-reporting-in/ The Peptide Newsroom en 2026-10-24 AI Scan of 150,000 Reddit Posts Finds Gray-Market Retatrutide Users Reporting Increased Appetite https://www.thepeptidenewsroom.com/umbrella-labs-standardizes-bpc-157-records-but-the-update-is-paperwork-not-scien/ The Peptide Newsroom en 2026-10-23 Umbrella Labs Standardizes BPC-157 Records, But the Update Is Paperwork, Not Science https://www.thepeptidenewsroom.com/telehealth-firms-market-off-label-glp-1s-for-addiction-but-no-drug-is-approved-y/ The Peptide Newsroom en 2026-10-23 Telehealth Firms Market Off-Label GLP-1s for Addiction, But No Drug Is Approved Yet https://www.thepeptidenewsroom.com/retatrutide-sourcing-checklist-sets-a-99-purity-bar-but-it-is-sponsored-content/ The Peptide Newsroom en 2026-10-23 Retatrutide Sourcing Checklist Sets a 99% Purity Bar, But It Is Sponsored Content https://www.thepeptidenewsroom.com/perelel-pairs-collagen-peptides-with-lactoferrin-but-the-immune-claim-has-no-pub/ The Peptide Newsroom en 2026-10-23 Perelel Pairs Collagen Peptides With Lactoferrin, But the Immune Claim Has No Published Study https://www.thepeptidenewsroom.com/combined-glp-1-and-sglt2-therapy-linked-to-fewer-amputations-in-diabetic-limb-di/ The Peptide Newsroom en 2026-10-23 Combined GLP-1 and SGLT2 Therapy Linked to Fewer Amputations in Diabetic Limb Disease